172 related articles for article (PubMed ID: 21711333)
1. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
[TBL] [Abstract][Full Text] [Related]
2. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for single and multiple basal cell carcinomas.
Kiiski V; de Vries E; Flohil SC; Bijl MJ; Hofman A; Stricker BH; Nijsten T
Arch Dermatol; 2010 Aug; 146(8):848-55. PubMed ID: 20713815
[TBL] [Abstract][Full Text] [Related]
4. Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice.
Flohil SC; van Tiel S; Koljenović S; Jaanen-van der Sanden G; Overbeek LI; de Vries E; Nijsten T
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):907-11. PubMed ID: 22211725
[TBL] [Abstract][Full Text] [Related]
5. [Basal cell carcinoma: often more than one].
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Ned Tijdschr Geneeskd; 2011; 155(47):A4110. PubMed ID: 22129810
[TBL] [Abstract][Full Text] [Related]
6. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
8. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
Flohil SC; de Vries E; Neumann HA; Coebergh JW; Nijsten T
Acta Derm Venereol; 2011 Jan; 91(1):24-30. PubMed ID: 21264452
[TBL] [Abstract][Full Text] [Related]
9. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
12. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
[TBL] [Abstract][Full Text] [Related]
14. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
Hoy WE
Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
[TBL] [Abstract][Full Text] [Related]
16. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
18. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
19. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
20. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial.
Pandeya N; Purdie DM; Green A; Williams G
Am J Epidemiol; 2005 Apr; 161(8):748-54. PubMed ID: 15800267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
